RBC Europe’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $220K | Hold |
1,538
| – | – | 0.01% | 196 |
|
|
2022
Q1 | $265K | Buy |
1,538
+5
| +0.3% | +$862 | 0.01% | 198 |
|
|
2021
Q4 | $389K | Sell |
1,533
-890
| -37% | -$226K | 0.02% | 168 |
|
|
2021
Q3 | $933K | Sell |
2,423
-229
| -9% | -$88.1K | 0.04% | 147 |
|
|
2021
Q2 | $623K | Buy |
2,652
+130
| +5% | +$30.5K | 0.03% | 183 |
|
|
2021
Q1 | $330K | Buy |
2,522
+917
| +57% | +$120K | 0.02% | 224 |
|
|
2020
Q4 | $168K | Sell |
1,605
-235
| -13% | -$24.6K | 0.01% | 312 |
|
|
2020
Q3 | $130K | Buy |
1,840
+460
| +33% | +$32.5K | 0.01% | 315 |
|
|
2020
Q2 | $88.6K | Sell |
1,380
-2,915
| -68% | -$187K | 0.01% | 350 |
|
|
2020
Q1 | $129K | Buy |
+4,295
| New | +$129K | 0.01% | 263 |
|